臭氧治疗治疗脑梗死基础与临床.pptVIP

臭氧自血回输治疗急性脑梗死 的基础与临床 ;医用臭氧发展简史;医用臭氧发展简史;臭氧治疗脑血管病的基础;臭氧治疗脑血管病的基础;臭氧治疗脑血管病的基础;臭氧治疗脑血管病的基础;臭氧治疗脑血管病的基础;臭氧治疗脑血管病的基础;臭氧治疗脑血管病的基础;臭氧治疗脑血管病的基础;臭氧临床治疗进展The Advances of Clinical Ozone Therapy2011国际臭氧治疗会议介绍The Introduction of 2011 Interventional Academical Ozone Therapy Congress ;臭氧的基础和临床研究; OZONE THERAPY IN DISEASES ASSOCIATION WITH ATHEROSCLEROSIS 臭氧治疗动脉粥样硬化相关性疾病 Oleg Mastennikov, Irina Gribkova, KlavdiyNizhny Novgorod State Medical Academy6 Nartova str., Nizhny Novgorod, 603104, Russia;154 patients with CHD, 102 patients with DM, and 84 patients with HD. The patients underwent the procedures of overall effect in the form of intravenous infusions of ozonated physiological solutions, major and minor autohemotnerapy, and rectal insufflations with an ozone- oxygen mixture. 本研究将臭氧治疗应用于154位冠心病患者、102位糖尿病患者和84为高血压患者。 患者接受了臭氧生理盐水静脉输入操作、大小自体血疗法和直肠臭氧氧气混合气体注入。 ;Positive clinical results were achieved in 91% of patients with CHD (elimination of 50% of the symptoms). Similar results were achieved in 90% of patients with DM of the 1st type and in 88% of patients with DM of the 2nd type. Positive indices of different manifestation levels were established in all patients with HD who used ozone therapy. 91%冠心病患者（消除了50%的症状）取得了阳性临床疗效。 90%的1型糖尿病患者和88%的2型糖尿病患者取得了相似的结果。 在使用臭氧疗法的所有高血压患者中发生了显著的不同水平的阳性变化。;During the exploration of the lipid exchange, a reduction of total cholesterol was found at an average of 10% in all cases, where it was originally increased (68% of CHD patients). In patients with HD this reduction was 5%; In patients with DM-9%. Evident decrease in the level of lipoproteins of low density was 12.5%, 9.6%, and 8%, respectively. 通过臭氧血液交换，冠心病所有病例的总体胆固醇平均下降了约10%，且治疗前大体都升高（68%的冠心病患者),高血压患者中下降了大概约5%； 糖尿病患者下降了约9%, 各病种的低密度脂蛋白分别降低12.5%、9.6%和8%。;The level of triglycerides was also decrease: in patients with CHD by 22%, in patients with DM by 17%. The atherogenicity coefficient in patients with CHD and HD was decreased by 12%, and in patient